Empyrean Capital Partners, LP Horizon Therapeutics Public LTD CO Transaction History

Empyrean Capital Partners, LP

  • $1.74 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$98.98 - $115.74 $18.2 Million - $21.3 Million
-184,000 Reduced 32.17%
388,000 $44.9 Million
Q2 2023

Aug 14, 2023
SELL
$96.34 - $112.38 $9.63 Million - $11.2 Million
-100,000 Reduced 14.88%
572,000 $58.8 Million
Q1 2023

May 15, 2023
BUY
$107.32 - $113.5 $40.5 Million - $42.8 Million
377,000 Added 127.8%
672,000 $73.3 Million
Q4 2022

Feb 14, 2023
BUY
$62.39 - $113.8 $18.4 Million - $33.6 Million
295,000 New
295,000 $33.6 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Empyrean Capital Partners, LP Portfolio

Follow Empyrean Capital Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empyrean Capital Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Empyrean Capital Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email